Incidence, risk factors, and the role of anticoagulation therapy in venous thromboembolism following radical cystectomy
Randall Bissette, Maxwell Sandberg, Stephen Tranchina, Kimberly Waggener, Madeline Snipes, Emily Ye, Jabrina Simmons, John Strobel, Ashok Hemal, Alejandro Rodriguez, Ronald Davis III · 2024
Read Incidence, risk factors, and the role of anticoagulation therapy in venous thromboembolism following radical cystectomy by Randall Bissette, Maxwell Sandberg, Stephen Tranchina, Kimberly Waggener, Madeline Snipes, Emily Ye, Jabrina Simmons, John Strobel, Ashok Hemal, Alejandro Rodriguez, Ronald Davis III (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11810684.txt.
Description
Bissette and co-authors count blood clots after bladder removal surgery and look for risk factors. The surgery, radical cystectomy, treats bladder cancer but brings many complications. Clots in veins, including lung clots, are a notable source of harm.
The team reviewed all such surgeries at their center from 2012 to 2024. They tracked clots within ninety days, plus drug use, surgery type, and hospital stays. Of 372 patients, 12, or 3.2 percent, developed a clot after surgery. The study also weighs the role of blood-thinning drugs given after discharge to prevent clots. The middle time to a clot fell between 31 and 90 days after discharge.
Catalog record
| CREATOR | Randall Bissette, Maxwell Sandberg, Stephen Tranchina, Kimberly Waggener, Madeline Snipes, Emily Ye, Jabrina Simmons, John Strobel, Ashok Hemal, Alejandro Rodriguez, Ronald Davis III |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |